Portfolio (Quarterly)
Guide ↗
Decheng Capital LLC
· CIK 0002010850| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CGON | CG ONCOLOGY INC | Healthcare | 6,371,669.0 | $264.6M | 35.59% | NEW | — | $41.52 | +65.6% |
| 2 | NUVB | Nuvation Bio Inc. | Healthcare | 25,954,439.0 | $232.6M | 31.28% | NEW | — | $8.96 | -36.0% |
| 3 | — | Upstream Bio Inc. | — | 3,143,078.0 | $85.3M | 11.48% | NEW | — | $27.15 | — |
| 4 | AARD | AARDVARK THERAPEUTICS INC | Healthcare | 3,917,299.0 | $51.4M | 6.92% | NEW | — | $13.12 | -57.7% |
| 5 | — | Lyell Immunopharma, Inc. | — | 692,050.0 | $21.3M | 2.87% | NEW | — | $30.78 | — |
| 6 | — | NEWAMSTERDAM PHARMA CO NV | — | 592,057.0 | $20.8M | 2.79% | NEW | — | $35.08 | — |
| 7 | RVMD | REVOLUTION MEDICINES INC(NSM) | Healthcare | 200,000.0 | $15.9M | 2.14% | NEW | — | $79.65 | +150.9% |
| 8 | RCUS | Arcus Biosciences, Inc | Healthcare | 541,559.0 | $12.9M | 1.74% | NEW | — | $23.83 | +5.2% |
| 9 | ACRS | Aclaris Therapeutics, Inc. | Healthcare | 4,041,736.0 | $12.2M | 1.64% | NEW | — | $3.01 | +78.7% |
| 10 | EQ | Equillium Inc. | Healthcare | 4,447,308.0 | $6.9M | 0.93% | NEW | — | $1.55 | +11.0% |
| 11 | BYSI | BeyondSpring Inc. | Healthcare | 3,800,702.0 | $6.2M | 0.83% | NEW | — | $1.63 | -55.5% |
| 12 | CRNX | CRINETICS PHARMACEUTICALS IN | Healthcare | 92,700.0 | $4.3M | 0.58% | NEW | — | $46.55 | +82.5% |
| 13 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 17,300.0 | $4.3M | 0.57% | NEW | — | $246.54 | +39.9% |
| 14 | AURA | Aura Biosciences, Inc. | Healthcare | 360,483.0 | $2.0M | 0.26% | NEW | — | $5.45 | +12.8% |
| 15 | ZNTL | Zentalis Pharmaceuticals Inc. | Healthcare | 1,323,327.0 | $1.8M | 0.24% | NEW | — | $1.35 | +103.7% |
| 16 | PYXS | Pyxis Oncology, Inc (formerly Apexigen) | Healthcare | 326,810.0 | $376K | 0.05% | NEW | — | $1.15 | +153.9% |
| 17 | FDMT | 4D MOLECULAR THERAPEUTICS IN | Healthcare | 44,311.0 | $332K | 0.04% | NEW | — | $7.50 | +96.1% |
| 18 | — | Nuvation Bio Inc. | — | 646,057.0 | $213K | 0.03% | NEW | — | $0.33 | — |
| 19 | RZLT | REZOLUTE INC | Healthcare | 59,900.0 | $141K | 0.02% | NEW | — | $2.36 | +66.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%